Chinese english Germany Japanese Korea

LY 2140023

LY 2140023 Struktur
635318-55-7
CAS-Nr.
635318-55-7
Englisch Name:
LY 2140023
Synonyma:
LY2140023 monohydrate;PoMagluMetad Methionil;VOYCNOJFAJAILW-CAMHOICYSA-N;Pomaglumetad methionil anhydrous;2-Thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid, 4-[[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino]-, 2,2-dioxide, (1R,4S,5S,6S)-
CBNumber:
CB42628059
Summenformel:
C12H18N2O7S2
Molgewicht:
366.41
MOL-Datei:
635318-55-7.mol
Request For Quotation

LY 2140023 Eigenschaften

Schmelzpunkt:
203 °C
Siedepunkt:
773.6±60.0 °C(Predicted)
Dichte
1?+-.0.1 g/cm3(Predicted)
pka
2.14±0.40(Predicted)

Sicherheit

LY 2140023 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

LY 2140023 is a drug developed as a treatment option for schizophrenia. It targets the mGlu2/3 receptor once metabolized.

LY 2140023 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LY 2140023 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
NCE Biomedical Co.,Ltd. 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
China 1494 55
TargetMol Chemicals Inc. 021-33632979 15002134094
 marketing@targetmol.com China 7934 58
LETOPHARM LIMITED +86-21-5821 5861
sales@letopharm.com China 2384 58
BOC Sciences --
 info@bocsci.com USA 0 65
Chunchuang (Wuhan) Technology Co., Ltd 15342225168
 yutianchun2007@126.com China 9964 58
cjbscvictory 13348960310 13348960310
 3003867561@qq.com China 9946 58
Abmole Bioscience Inc. 021-50967598 02150967598
 sales@abmole.cn China 4495 58
  • PoMagluMetad Methionil
  • VOYCNOJFAJAILW-CAMHOICYSA-N
  • LY2140023 monohydrate
  • 2-Thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid, 4-[[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino]-, 2,2-dioxide, (1R,4S,5S,6S)-
  • Pomaglumetad methionil anhydrous
  • 635318-55-7
Copyright 2019 © ChemicalBook. All rights reserved